Sanofi-Aventis pays up for Eu3.7bn extension
French pharmaceuticals group Sanofi-Aventis has secured a Eu3.7bn one year extension to an outstanding loan maturing next week, after agreeing to increase the margin and commitment fee. The new loan, which will become effective on January 14 and is one of the first chunky deals to be completed this year, replaces a Eu4.08bn facility signed in 2008.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
